Development of AIDA v4.3b Diabetes Simulator: Technical Upgrade to Support Incorporation of Lispro, Aspart, and Glargine Insulin Analogues

<table class="table-group" id="tab4"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td align="left">Injected dose/IU</td><td align="center">Injected volume/mL</td><td align="center">Radius of 15th sphere/mm</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td align="left">1</td><td align="center">0.01</td><td align="center">3.4 mm</td></tr><tr><td align="left">2</td><td align="center">0.02</td><td align="center">4.2 mm</td></tr><tr><td align="left">5</td><td align="center">0.05</td><td align="center">5.8 mm</td></tr><tr><td align="left">10</td><td align="center">0.1</td><td align="center">7.3 mm</td></tr><tr><td align="left">20</td><td align="center">0.2</td><td align="center">9.1 mm</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Radius of the 15th sphere for various injected volumes of U100 (100 mIU/L) insulin.

Journal of Electrical and Computer Engineering

tab4

Table 4

Table 4: Development of AIDA v4.3b Diabetes Simulator: Technical Upgrade to Support Incorporation of Lispro, Aspart, and Glargine Insulin Analogues 